分數血流儲備（FFR）設備市場規模、佔有率和成長分析：按設備類型、最終用戶、應用、銷售管道、材料類型和地區分類－2026-2033年產業預測

2024 年全球部分血流儲備 (FFR) 設備市場價值為 13 億美元，預計到 2025 年將成長至 14.3 億美元，到 2033 年將成長至 30.7 億美元，在預測期（2026-2033 年）內複合年成長率為 10.0%。

世界のフラクショナル,フロー,リザーブ（FFR）デバイス市場は、不必要な介入を最小限に抑えつつ患者の転帰を改善する上で、FFRに基づく意思決定の有効性を示す強力な臨床的エビデンスによって主に牽引されています。この市場には、冠動脈攝影術中に使用され、病変の機能的意義を評価することで過剰治療を防ぎ、コストを最適化する圧力感知導管導引線が含まれます。ワイヤー設計やセンサー技術の進歩に伴い、iFRやFFR CTなどの代替技術が世界中で臨床応用を拡大しています。さらに、実証された費用対効果に基づく償還獎勵の整備により、病院はFFR技術への投資を促進されています。AIの統合により、標準的な画像診断を生理学的評価へと変換することで診断精度が向上し、ワークフローのさらなる効率化と侵襲的処置への依存低減が圖られ、最終的には医療システムや市場全体での導入拡大が促進されます。

全球部分血流儲備（FFR）設備市場的成長要素

冠狀動脈疾病及相關缺血性疾病發生率的上升顯著推動了對生理評估工具的需求。這是因為醫療專業人員越來越需要可靠的方法來做出明智的重組選擇。心臟科醫師日益認知到評估生理病變的重要性，促使導管檢查室更廣泛地採用血流儲備分數（FFR）設備。此外，複雜冠狀動脈疾病患者的增多導致手術數量持續成長，進一步加劇了這項臨床需求。醫院和診所越來越願意採用這些技術，這鼓勵了對FFR解決方案的投資，並促使製造商專注於改進和推廣其產品，以滿足不斷成長的醫療需求。

全球分數血流儲備（FFR）設備市場的限制因素

全球部分血流儲備（FFR）設備市場面臨諸多限制因素，阻礙其廣泛應用。設備採購、耗材以及醫護人員的專業訓練等相關高昂成本，尤其對於預算有限的醫院和診所而言，可能構成阻礙。此外，與生理評估相關的報銷政策不明確或限制性強，削弱了醫療機構改善現有臨床方案的經濟動力，導致他們更傾向於選擇其他診斷方法。因此，這些經濟因素迫使決策者將重點放在收益前景更明朗的投資項目上，從而延長了採購流程，並限制了FFR設備在資源匱乏的醫療環境中的應用。

全球分數血流儲備（FFR）設備市場趨勢

全球血流儲備分數（FFR）設備市場正經歷顯著成長，這主要得益於先進成像平台與導管檢查室的整合。這種整合簡化了手術流程，並加強了設備製造商與臨床合作夥伴之間的協作。互通性的提升使得血流動力學與解剖影像的即時視覺化成為可能，從而提高了決策效率並簡化了手術流程。這一趨勢推動了對軟體相容性、培訓項目以及供應商間合作夥伴關係的投資，強調無縫數據交換並增強臨床醫生的信心。因此，醫院能夠更好地應用這些技術，最終提升介入心臟病學治療的品質。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球分數血流儲備（FFR）設備市場規模：按設備類型分類

• 侵入性設備
  • 壓力線系統
  • 非侵入式設備
• FFR測量技術
  • 瞬時FFR
  • 靜止FFR

全球分數血流儲備（FFR）設備市場規模：依最終用戶分類

• 醫院
  • 循環系統
  • 心臟外科中心
• 門診手術中心
  • 門診心臟病中心
  • 私人診所

全球分數血流儲備（FFR）設備市場規模：按應用分類

• 冠狀動脈疾病
  • 穩定性冠狀動脈疾病
  • 不穩定型冠狀動脈疾病
• 心臟瓣膜疾病
  • 主動脈瓣狹窄
  • 二尖瓣疾病

全球部分血流儲備（FFR）設備市場規模：依銷售管道分類

• 直銷
  • 廠商直銷
  • 與銷售代理商合作
• 線上銷售
  • 電子商務平台
  • 企業網站

全球分數血流儲備（FFR）設備市場規模：依材料類型分類

• 生物相容性材料
  • 塑膠部件
  • 複合材料
• 非生物相容性材料

全球分數血流儲備（FFR）設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• Philips Healthcare
• Boston Scientific
• Medtronic
• Siemens Healthineers
• Acist Medical Systems
• Cardiac Science
• Acacia Pharma
• Avinger
• OrbusNeich
• St. Jude Medical
• Neovasc
• iVascular
• CardioComm Solutions
• Asahi Intecc
• Catheter Precision
• Pressure Products Medical
• Terumo Corporation
• Cardiovascular Systems
• TriReme Medical

結論與建議

Global Fractional Flow Reserve Devices Market size was valued at USD 1.3 Billion in 2024 and is poised to grow from USD 1.43 Billion in 2025 to USD 3.07 Billion by 2033, growing at a CAGR of 10.0% during the forecast period (2026-2033).

The global fractional flow reserve (FFR) devices market is primarily driven by strong clinical evidence that demonstrates the effectiveness of FFR-guided decision-making in improving patient outcomes while minimizing unnecessary interventions. This market includes pressure-sensing guidewires utilized during coronary angiography to evaluate the functional significance of lesions, thus preventing overtreatment and optimizing costs. With advancements in wire design and sensor technology, alternatives like iFR and FFR CT are broadening clinical applications worldwide. Additionally, the alignment of reimbursement incentives with proven cost-effectiveness encourages hospitals to invest in FFR technology. The integration of AI enhances diagnostic precision by transforming standard imaging into physiological assessments, further streamlining workflows and reducing reliance on invasive measures, ultimately fostering greater adoption across healthcare systems and markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fractional Flow Reserve Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fractional Flow Reserve Devices Market Segments Analysis

Global fractional flow reserve devices market is segmented by device type, end user, application, sales channel, material type and region. Based on device type, the market is segmented into Invasive Devices and FFR Measurement Techniques. Based on end user, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on application, the market is segmented into Coronary Artery Disease and Heart Valve Diseases. Based on sales channel, the market is segmented into Direct Sales and Online Sales. Based on material type, the market is segmented into Biocompatible Materials and Non-Biocompatible Materials. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fractional Flow Reserve Devices Market

The heightened incidence of coronary artery disease and associated ischemic conditions is significantly driving the demand for physiological assessment tools, as healthcare professionals increasingly pursue dependable methods for making informed revascularization choices. The growing recognition among cardiologists regarding the importance of evaluating physiological lesions has led to a wider acceptance of fractional flow reserve devices in catheterization labs. Additionally, patients with complex coronary disease contribute to sustained procedural volumes, thereby reinforcing this clinical demand. Hospitals and clinics are more inclined to procure these technologies, prompting investment in FFR solutions and motivating manufacturers to focus on advancing and distributing their products to address the escalating healthcare requirements.

Restraints in the Global Fractional Flow Reserve Devices Market

The global market for fractional flow reserve devices faces several constraints that hinder widespread adoption. High procedural costs linked to device procurement, disposable materials, and necessary specialized training for staff may discourage hospitals and clinics, especially those with restricted budgets. Additionally, unclear or restrictive reimbursement policies concerning physiological assessments diminish financial motivation for providers to alter existing care protocols, resulting in a preference for alternative diagnostic methods. As a result, these economic factors compel decision-makers to focus on investments with more defined return potentials, leading to prolonged procurement processes and limiting the integration of FFR devices in resource-constrained healthcare environments.

Market Trends of the Global Fractional Flow Reserve Devices Market

The Global Fractional Flow Reserve Devices market is experiencing a significant upward trend fueled by the integration of advanced imaging platforms within catheterization labs. This integration fosters streamlined procedural workflows, enhancing collaboration between device manufacturers and clinical partners. Improved interoperability allows for real-time visualization of hemodynamics alongside anatomical imaging, leading to more efficient decision-making and simplified procedures. This trend drives investments in software compatibility, training programs, and collaborative vendor partnerships, emphasizing seamless data exchange and boosting clinician confidence. As a result, hospitals are better equipped to adopt these technologies, ultimately elevating the quality of care within cardiovascular interventions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Fractional Flow Reserve Devices Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Invasive Devices
  • Pressure Wire Systems
  • Non-Invasive Devices
• FFR Measurement Techniques
  • Instantaneous FFR
  • Resting FFR

Global Fractional Flow Reserve Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
  • Cardiology Units
  • Cardiac Surgery Centers
• Ambulatory Surgical Centers
  • Outpatient Cardiac Centers
  • Private Clinics

Global Fractional Flow Reserve Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Coronary Artery Disease
  • Stable CAD
  • Unstable CAD
• Heart Valve Diseases
  • Aortic Valve Stenosis
  • Mitral Valve Disorders

Global Fractional Flow Reserve Devices Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
  • Manufacturer Direct
  • Distributor Partnerships
• Online Sales
  • E-commerce Platforms
  • Company Websites

Global Fractional Flow Reserve Devices Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Biocompatible Materials
  • Plastic Components
  • Composite Materials
• Non-Biocompatible Materials

Global Fractional Flow Reserve Devices Market Size & CAGR (2026-2033)

• North America (Device Type, End User, Application, Sales Channel, Material Type)
  • US
  • Canada
• Europe (Device Type, End User, Application, Sales Channel, Material Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, End User, Application, Sales Channel, Material Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, End User, Application, Sales Channel, Material Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, End User, Application, Sales Channel, Material Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acist Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acacia Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avinger
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrbusNeich
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iVascular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioComm Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catheter Precision
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pressure Products Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriReme Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations